Table 5.
Survival analysis for patients with BRAFV600E mutated colorectal cancer.
| mOS (months) | P-value | |
|---|---|---|
| Gender | ||
| Male | 24.7 | |
| Female | 23.1 | 0.8116 |
| Age | ||
| <49 | 24.8 | |
| >48 | 23.0 | 0.4016 |
| Location | ||
| Right-sided colon | 26.1 | |
| Left-sided colon | 24.8 | |
| Rectum | 22.4 | 0.6703 |
| TMB (Mut/Mb) | ||
| <7.2 | 29.4 | |
| >7.1 | NA | 0.5491 |
| CDX2 | ||
| Negative | 9.4 | |
| Positive | NA | 0.016 |
| TNM stage | ||
| II | NA | |
| III | 23.1 | |
| IV | 22.4 | 0.3134 |